Forbion Capital sells PneumRx
Forbion Capital Partners has sold PneumRx to BTG. Cash consideration was $230 million and up to $245 million in performance related future milestone payments.PneumRx is a interventional pulmonology business that makes and distributes the RePneu Coil System, which aims to treat advanced emphysema.
4 December 2014•3 mins read
